FIGS, Inc. (NYSE: FIGS) carried out has moderately properly when concentrating on expanding its group of lively clients. In its recent Q3 2022 earnings report, administration stated that it observed a report degree of customer reactivation. These are the shoppers who have returned to FIGS soon after a 12-month lapse. FIGS is also expanding its products line over and above scrubs. Its current expansion, way of living choices, generated 65% of in general sales advancement. The business has been in a position to expand its complete addressable current market (TAM) because of to the products line expansion.
Although there are numerous positives for FIGS, I continue to have worries about the firm’s present monetary position. These positives are not tantamount to its future earnings and expansion. Although I believe that FIGS has the probable to expand, it truly is facing numerous setbacks at the moment. These concerns require to be tackled ahead of we permit optimism to overpower our expenditure choice.
FIGS is a direct-to-purchaser (DTC) health care clothing firm headquartered in Santa Monica, Calif. It patterns and sells scrubs primarily for healthcare gurus. It intends to broaden its buyer base through its DTC small business tactic. It also intends to lengthen its item line over and above scrubs to consist of other outfits and add-ons for the healthcare marketplace. Alongside with emphasizing its goods, FIGS destinations a priority on company social duty. The firm has been in a growth phase considering that its inception in 2013. It went public on the NYSE in 2021.
Health care Materials Market Examination
The health care supply business is comprised of providers that give medical products, machines, and provides essential for the analysis, procedure, and management of diseases and other medical situations. This marketplace is an essential section of the healthcare sector. It gives obtain to devices that healthcare pros have to have to supply safe treatment.
According to a report by Marketplaces And Marketplaces, international health-related materials industry dimensions is projected to increase by 3.4% in the up coming number of years. The benefit is approximated to achieve $164 billion by 2027. Just one of the key motorists for this progress is the getting old inhabitants. This is main to an raise in long-term conditions this kind of as cancer, diabetes, and cardiovascular conditions. Moreover, the COVID-19 pandemic greater desire for individual protective tools (PPE) to protect healthcare pros from infectious illnesses.
Nevertheless, the rise in inflation has slowed the growth of this industry down a bit. This is primarily simply because of the hurdles in the source chain, thereby increasing stock fees. But I feel this is a temporary setback. This market has developing demand from customers from buyers, not only in North The us but globally as nicely.
With its DTC organization design, FIGS is ready to gauge the person knowledge intently. They have been ready to innovate their product or service designs and shades based on buyer opinions. Of the purchaser testimonials that I have occur across, most assert that they are content with its excellent and toughness. There are some who have concerns with its pricing, but these have been just a handful. I imagine that FIGS’s concentration on corporate social accountability initiatives also resonates with its prospects. This was reflected in the buyer opinions as effectively. In addition, they were capable to extend their energetic prospects by 24% in Q3 2022 on a very last 12 months (LTM) foundation.
FIGS can also reap the gains of the increasing industry dimension of the healthcare offer field. Growing needs for this type of clothing by health care pros will most likely mirror expansion in FIGS’s earnings. For that subject, earnings approximately doubled due to the fact 2020, at this time standing at $490 million. Having said that, earnings development considering that December 2021 was only 6%. There are several opportunities for this restricted revenue expansion. The big a person can be attributed to the increase in inflation. This might have led to an boost in value of revenues. Consumers also come to be frugal with their paying, which may possibly have restricted their buys.
That reported, FIGS is also increasing its presence internationally, generally in Canada, the Uk, and other European markets. This led to an improve of 49% in web profits in Q3 2022. In 2020, surgical drapes, scrubs, and gowns comprised 35% of the U.S. health care source. This composition continues to persist. Also, FIGS mostly manufactures these quite merchandise. It is also growing its products line to other health care equipment. Therefore, I consider the demand from customers for these items will eventually profit the earnings and growth of FIGS.
My primary problem with FIGS’s financials is the growing value of stock. Its stock has doubled in the very last 12 months, reaching $170 million. As talked about previously, this could be mainly due to climbing inflation foremost to declines in purchases. In addition, escalating labor and material charges may possibly influence margins.
Extra inventory can tie up a firm’s cash flow and storage area. This can also have an effect on overall margins. The influence on money movement from operations can be noticed in its hard cash stream statement. Now, its cash flow from operations is down by $26 million for the past year. There was also no major profits advancement in the final 12 months. If this circumstance persists, it can be a bring about of issue for investors. On the other hand, due to the fact the firm is closely investing in expanding its functions globally alongside with its product or service line, I can price reduction this concern for its growth initiatives. That mentioned, this circumstance must not be forgotten. Because its inception, its overall return dropped by 48% (see under). This might not strengthen whenever quickly due to the ongoing setbacks.
The health care sector as a full also comes with regulatory threats and alterations in health care policies. Thus, regardless of the progress prospective buyers, the healthcare offer field faces numerous difficulties. These problems not only incorporate rigid regulatory specifications, but also difficulties these as high production expenditures and a scarcity of expert labor. We have to have to take into consideration these variables although producing an investment decision conclusion in addition to the intrinsic fiscal factors of the organization.
I have used P/E (cost to earnings) multiples and EV/EBITDA (enterprise benefit to EBITDA) valuation methods when analyzing FIGS. I have not used a DCF (discounted funds movement) valuation technique for the reason that there just isn’t ample details on analyzing its dollars flow craze. What’s more, given that FIGS is in a substantial-growth phase with negative trailing 12 months (TTM) levered totally free funds movement, the DCF technique isn’t really justified. It has a TTM P/E ratio of 58 vs. a sector-median P/E ratio of 25. This price is far more than double when as opposed to the sector. We have to have to understand that P/E ratio on your own can not justify a company’s growth amount. A bigger P/E ratio can also necessarily mean that the organization is overvalued.
Based on my intrinsic valuation noted over, we can see that the normal share value will come out to around $6.70. But, FIGS is at the moment investing at $9.80. FIGS saw a 12% maximize in its share price above the very last pair of months. This is viewed as to be the aftermath of an analyst’s raised earnings estimate. Investors flocked to the shares, generating assumptions about its growth and the firm’s potential to combat troubles linked to inflation.
Even nevertheless there is just not a significant change among my evaluated normal share selling price and the present share cost, I am nevertheless anxious about its TTM earnings for each share of just $.18. This is not in line with its present share value. It also has a PEG (price tag to earnings to progress) ratio of 29 at present, which is way above the fair industry benefit. This is all over again because of to enhanced optimism in its progress price. As these, I consider that FIGS is at least reasonably overvalued.
Given the projected development in the health care provide marketplace, I imagine that FIGS will seize the possibility to grow its sector sizing. The ongoing innovations and expanding demand from customers in this business will improve FIGS’s revenues. Management is concentrating on advertising and marketing to acquire far more prospects. With its DTC enterprise strategy, I believe that FIGS has the opportunity to enhance its consumer foundation and retention charge. Having said that, its present-day stock prices and weak valuation issue me. Hence, for now, I charge FIGS a hold.